ICAAC Underway This Week in Denver

The 53nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2013) kicked off Tuesday and runs throughout the week in Denver. will be on site to cover the latest research on HIV and hepatitis B and C.


U.S. Conference on AIDS Focuses on Epidemic in the South

The annual U.S. Conference on AIDS (USCA 2013), sponsored by the National Minority AIDS Council, took place this week in New Orleans, highlighting the burgeoning HIV epidemic in the southern states. Other themes included the Affordable Care Act, HIV prevention, aging, and fighting HIV stigma and criminalization.alt

Neurocognitive Impairment Common Among Youth with HIV

Approximately two-thirds of HIV positive young adults showed evidence of HIV-associated neurocognitive disorders (HAND), including impaired memory and fine motor control, according to a report in the August 21, 2013, advance edition of the Journal of Adolescent Health.


Food Insecurity Predicts Worse Outcomes for People with HIV

Lack of adequate nutrition was associated with reduced adherence to antiretroviral treatment, incomplete viral load suppression, and lower CD4 cell counts among HIV positive people in both Uganda and San Francisco, according to 2 recently published studies.


Early Time-limited Treatment Leads to Better Outcomes for Infants with HIV

Infants with HIV who start antiretroviral therapy (ART) immediately after birth had a lower risk of disease progression or death and were able to safely interrupt treatment longer than children who started ART later, according to findings from the long-running CHER study published in the August 22, 2013, advance online edition of The Lancet.


Recent Studies Shed Light on Cancer Among People with HIV

Starting antiretroviral therapy (ART) with a low CD4 count raises the likelihood of certain cancers, but others increase with longer time on therapy, reflecting a rising risk associated with older age, according to a recently published study. Other new research revealed increases in malignancies related to viral infections and a higher risk of Kaposi sarcoma even after immune restoration.


Increased Risk of AIDS-defining Illnesses Seen Even at CD4 Counts of 500-750

HIV positive people with CD4 T-cell counts in the 500-749 cells/mm3 range still have a higher risk of AIDS-defining illnesses -- especially cancers -- compared to those with more than 1000 cells/mm3, although the risk is quite low, according to a study published in the August 6, 2013, advance edition of Clinical Infectious Diseases. These findings offer further evidence of the benefits of prompt antiretroviral treatment.